Article Text
Statistics from Altmetric.com
Commentary on: de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, et al. Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. Lancet 2017;390:959–68.
Context
Inflammatory bowel disease (IBD) is a chronic heterogeneous disease with high complexity, often requiring intensive management by a gastroenterologist and ancillary team with the goal of achieving clinical remission. Multiple prior studies have demonstrated the feasibility of implementing telemedicine into IBD practices via various technological platforms with resulting improved quality of life, disease knowledge and adherence, and a decrease in hospitalisations, emergency room visits and steroid use.1-3 This randomised controlled trial (RCT) examines quality of life and healthcare utilisation after implementation of a telemedicine system in four IBD practices in the Netherlands.4
Methods
This study was a pragmatic RCT comparing remote monitoring with telemedicine to standard of care. The system included monitoring of …